Specialty was always going to be hit hard from COVID. When E4 launches it will triple in size. This is a reasonable result all things considered, and for the broad business it shows stabilization for H1 to H2 with a pandemic in the middle. Now, we sit and wait for big FDA approvals x2 this half and E4 next half.
MYX Price at posting:
35.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)